Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Trial of Inhaled Alprostadil to Improve Hypoxia and Pulmonary Hypertension

NCT00314548 is registered in ClinicalTrials.gov with Aga Khan University as lead sponsor.

NCT NCT00314548
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00314548 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Trial of Inhaled Alprostadil to Improve Hypoxia and Pulmonary Hypertension
Lead sponsor
Aga Khan University
Phase
Not applicable
Overall status
Completed
Start date
May 31, 2006
Completion date
July 31, 2009
Enrollment
67 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

adult respiratory distress syndrome, pulmonary hypertension